FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wendell Rosse

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Co-author Network

Publications

TOP 3
H Franklin Bunn; David G Nathan; George J Dover; Robert P Hebbel; Orah S Platt; Wendell F Rosse; Russell E Ware
Pulmonary hypertension and nitric oxide depletion in sickle cell disease.
Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell F Rosse; Gérard Socié
Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
Jun-ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M DeCastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wendell Rosse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: H Franklin Bunn; David G Nathan; George J Dover; Robert P Hebbel; Orah S Platt; Wendell F Rosse; Russell E Ware
Pulmonary hypertension and nitric oxide depletion in sickle cell disease.
Blood 2010;116(5):687-92.
2005: Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell F Rosse; Gérard Socié
Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
Blood 2005;106(12):3699-709.
2004: Jun-ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M DeCastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.
Medicine 2004;83(3):193-207.
2004: Wendell F Rosse; Peter Hillmen; Alan D Schreiber
Immune-mediated hemolytic anemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():48-62.
2003: Wendell F Rosse; Junichi Nishimura
Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems.
International journal of hematology 2003;77(2):113-20.
2002: Jun-ichi Nishimura; Russell E Ware; Angela Burnette; Andrew L Pendleton; Kiyoshi Kitano; Toshiyuki Hirota; Takashi Machii; Teruo Kitani; Clay A Smith; Wendell F Rosse
The hematopoietic defect in PNH is not due to defective stroma, but is due to defective progenitor cells.
Blood cells, molecules & diseases 2002;29(2):159-67.
2002: Wendell F Rosse
Clinical management of adult ITP prior to splenectomy: a perspective.
Blood reviews 2002;16(1):47-9.
2001: Kenneth L Phillips; Russell E Ware; S Hall; L Wilson; Tracy Gentry; Thad A Howard; Y Murakami; Makio Shibano; Takashi Machii; Eli Gilboa; Yuzuru Kanakura; J Takeda; Taroh Kinoshita; Wendell F Rosse; Clay A Smith
Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Blood 2001;97(10):3004-10.
2001: Wendell F Rosse
New insights into paroxysmal nocturnal hemoglobinuria.
Current opinion in hematology 2001;8(2):61-7.
2000: V N Hanft; S R Fruchtman; Chrisley V Pickens; Wendell F Rosse; Thad A Howard; Russell E Ware
Acquired DNA mutations associated with in vivo hydroxyurea exposure.
Blood 2000;95(11):3589-93.
1999: D B Purow; Thad A Howard; SJ Marcus; Wendell F Rosse; Russell E Ware
Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria.
Blood cells, molecules & diseases 1999;25(2):81-91.
1999: Sherri A Zimmerman; Erin O'Branski; Wendell F Rosse; Russell E Ware
Hemoglobin S/O(Arab): thirteen new cases and review of the literature.
American journal of hematology 1999;60(4):279-84.
1998: Russell E Ware; Jun-ichi Nishimura; M Anthony Moody; Clay Smith; Wendell F Rosse; Thad A Howard
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.
Blood 1998;92(7):2541-50.
1998: Jun-ichi Nishimura; Clay A Smith; Kenneth L Phillips; Russell E Ware; Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
Hematopathology and molecular hematology 1998;11(3-4):119-46.
1997: Wendell F Rosse
The natural history of paroxysmal nocturnal hemoglobinuria.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1997;49 Suppl 1():8-9.
1997: Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria as a molecular disease.
Medicine 1997;76(2):63-93.
1996: Wendell F Rosse
Epidemiology of PNH.
Lancet 1996;348(9027):560.
1996: S E Hall; Wendell F Rosse
The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
Blood 1996;87(12):5332-40.
1996: M L Graham; Wendell F Rosse; E C Halperin; Cameron R Miller; Russell E Ware
Resolution of Budd-Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria.
British journal of haematology 1996;92(3):707-10.
1996: J Petranka; J Zhao; J Norris; N B Tweedy; Russell E Ware; P J Sims; Wendell F Rosse
Structure-function relationships of the complement regulatory protein, CD59.
Blood cells, molecules & diseases 1996;22(3):281-96.
1995: Wendell F Rosse; Russell E Ware
The molecular basis of paroxysmal nocturnal hemoglobinuria.
Blood 1995;86(9):3277-86.
1995: Russell E Ware; Wendell F Rosse; S E Hall
Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria.
Blood 1995;86(4):1586-9.
1994: J R Casey; J G Petranka; J Kottra; D E Fleenor; Wendell F Rosse
The structure of the urokinase-type plasminogen activator receptor gene.
Blood 1994;84(4):1151-6.
1994: Russell E Ware; Wendell F Rosse; Thad A Howard
Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria.
Blood 1994;83(9):2418-22.
1994: Ala I Sharara; R E Hillsley; T D Wax; Wendell F Rosse
Paroxysmal cold hemoglobinuria associated with non-Hodgkin's lymphoma.
Southern medical journal 1994;87(3):397-9.
1994: J Norris; S Hall; Russell E Ware; T Kamitani; H M Chang; Elaine Yeh; Wendell F Rosse
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step.
Blood 1994;83(3):816-21.
1993: Wendell F Rosse
The glycolipid anchor of membrane surface proteins.
Seminars in hematology 1993;30(3):219-31.
1993: Wendell F Rosse
Evolution of clinical understanding: paroxysmal nocturnal hemoglobinuria as a paradigm.
American journal of hematology 1993;42(1):122-6.
1992: J G Petranka; D E Fleenor; K Sykes; Russel E Kaufman; Wendell F Rosse
Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(17):7876-9.
1992: J F Mahoney; Masaharu Urakaze; S Hall; R DeGasperi; H M Chang; E Sugiyama; C D Warren; Michael J Borowitz; A Nicholson-Weller; Wendell F Rosse
Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.
Blood 1992;79(6):1400-3.
1992: Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria.
Current topics in microbiology and immunology 1992;178():163-73.
1991: Russell E Ware; S E Hall; Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence.
The New England journal of medicine 1991;325(14):991-6.
1991: Gerold Bepler; S E Hoffman; B P Thompson; Marilyn J Telen; Wendell F Rosse
Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura.
Transfusion 1991;31(8):752-5.
1991: Wendell F Rosse; S Hoffman; M Campbell; Michael J Borowitz; Joseph O Moore; C J Parker
The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
British journal of haematology 1991;79(1):99-107.
1991: A T Huang; T J Panella; N G Mold; Wendell F Rosse
Absence of phosphatidylinositol (PI)-linked proteins in a very early human multipotential haematopoietic marrow cell.
British journal of haematology 1991;77(2):145-9.
1990: Wendell F Rosse; D Gallagher; Thomas R Kinney; O Castro; H Dosik; J Moohr; W Wang; P S Levy
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.
Blood 1990;76(7):1431-7.
1990: Wendell F Rosse
Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria.
Blood 1990;75(8):1595-601.
1990: Marilyn J Telen; Wendell F Rosse; C J Parker; Marilyn K Moulds; J J Moulds
Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins.
Blood 1990;75(7):1404-7.
1990: J Sugarman; W M Samuelson; R H Wilkinson; Wendell F Rosse
Pulmonary embolism and splenic infarction in a patient with sickle cell trait.
American journal of hematology 1990;33(4):279-81.
1990: Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria and decay-accelerating factor.
Annual review of medicine 1990;41():431-6.
1989: Wendell F Rosse
Paroxysmal nocturnal hemoglobinuria: the biochemical defects and the clinical syndrome.
Blood reviews 1989;3(3):192-200.
1988: Marilyn J Telen; S E Hall; A M Green; J J Moulds; Wendell F Rosse
Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.
The Journal of experimental medicine 1988;167(6):1993-8.
1987: Roger Kurlander; R Edward Coleman; J Moore; Jon P Gockerman; Wendell F Rosse; R Siegal
Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults.
The American journal of medicine 1987;83(4A):17-24.
1987: O E Akwari; K M Itani; R Edward Coleman; Wendell F Rosse
Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results.
Annals of surgery 1987;206(4):529-41.
1971: Wendell F Rosse
Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment.
The Journal of clinical investigation 1971;50(4):734-43.